Roche Highlights its Response to COVID-19 Pandemic

 Roche Highlights its Response to COVID-19 Pandemic

Roche Highlights its Response to COVID-19 Pandemic

Shots:

  • On Mar 19, 2020, the company initiates the global P-III study in collaboration with BARDA to assess the efficacy of Actemra/RoActemra (tocilizumab, IV) + SOC vs PBO + SOC in hospitalized patients with severe COVID-19 pneumonia
  • Roche facilitates the delivery and production of Actemra and is working continuously to increase the availability of COVID 19-tests as its test has received FDA’s EUA for its SARS-CoV-2 test
  • Roche is working with governments across the globe to work closely with industry to keep manufacturing and supply running to tackle the pandemic

Click here ­to­ read full press release/ article | Ref: Roche | Image: Pinterest

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post